Search - tctmd.com

Displaying 1 - 20 of 92

Sort: Relevancy | Date

Presentation TCT India 2025

DAPT in STEMI – Do We Have Clarity on Drug, Dose and Duration?

Presenter: Rishi Sethi

July 26, 2025

Presentation TCT 2023

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Presenter: Pieter Smits

October 25, 2023

Presentation TCT 2023

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

Presenter: Byeong-Keuk Kim

October 25, 2023

Presentation TCT 2023

DAPT Duration: Unsettled or Case Closed?

Presenter: Duk-Woo Park

October 24, 2023

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

Presentation TCT 2021

DAPT Duration in the Afib Patient: Where Do We Stand?

Presenter: Renato Lopes

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

Presenter: Marco Valgimigli

November 05, 2021

Presentation TCT 2021

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Presenter: Davide Cao

November 05, 2021

Presentation TCT 2019

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Presenter: Adrian Magee

September 27, 2019

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in India

Presenter: Upendra Kaul

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in China

Presenter: Run-Lin Gao

September 26, 2019

Presentation TCT 2019

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Presenter: Robert de Winter

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Presenter: Takeshi Kimura

September 26, 2019

Presentation TCT 2019

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Presenter: Sripal Bangalore

September 26, 2019

Presentation TCT 2019

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Presenter: Greg Kaluza

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Advertisement

DAPT in STEMI – Do We Have Clarity on Drug, Dose and Duration?

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation

DAPT Duration: Unsettled or Case Closed?

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

DAPT Duration in the Afib Patient: Where Do We Stand?

DAPT Duration in High Bleeding Risk Patients: Lessons From RCTs

DAPT Duration in High Bleeding Risk Patients: Lessons From Registries

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Defining High Bleeding Risk: HBR ARC

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Primer on Metallic Stents Developed in India

Primer on Metallic Stents Developed in China

Pro-Healing Stents (With Active and Passive Coatings): Latest Clinical Evidence

Polymer-Free DES: Lessons Learned From Recent Trials

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

The Case for Further Reducing Strut Thickness: Technical Challenges and Clinical Benefits

Impact of Stent Design Features on Vascular Healing and Surface Thrombogenicity: What Really Matters?

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content